Global Surgical Stents Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In May 2016, Boston Scientific collaborated with Mayo Clinic (U.S.) to share intellectual property and speed the development of medical devices. This collaboration focuses on the development of medical technologies in the fields of interventional cardiology, heart rhythm management, endoscopy, neuromodulation, urology and pelvic health. This will help the company to strengthen its product offerings.

• In January 2016, Abbott acquired St. Jude Medical, Inc. (U.S.), a manufacturer of products for heart failure, atrial fibrillation, and cardiac rhythm management for USD 25 billion. The acquisition helped Abbott to strengthen its coronary intervention product offerings and increase its presence in the cardiovascular devices market

The global surgical stents market is segmented into product type, material, application, and end-user. By product type, vascular stents hold the largest market share due to their critical role in managing cardiovascular diseases. These stents, including bare-metal stents, drug-eluting stents, and bioresorbable vascular scaffolds, are integral to coronary and peripheral artery interventions. Non-vascular stents, such as biliary, urinary, and esophageal stents, address the growing need for minimally invasive solutions in managing non-cardiovascular obstructions. The rising incidence of conditions such as biliary strictures, ureteral obstructions, and esophageal cancers has driven the adoption of these devices, contributing significantly to the market’s expansion.

Material-wise, metal stents, typically made from stainless steel or nitinol, are widely used due to their durability and cost-effectiveness. However, the emergence of standard and biodegradable polymers has revolutionized the stent market by offering enhanced biocompatibility and reducing long-term complications. Biodegradable polymer stents, in particular, are gaining traction for their ability to provide temporary support and naturally dissolve over time, minimizing the risk of chronic inflammation or late thrombosis. This material innovation aligns with the growing demand for safer and more patient-friendly medical devices.

By application, cardiac diseases dominate the market, driven by the high global burden of coronary artery disease. The increasing adoption of percutaneous coronary interventions (PCI) has further fueled the demand for cardiac stents. Urinary tract diseases represent another significant application segment, where stents are used to alleviate obstructions caused by kidney stones, tumors, or strictures. Other applications, including biliary and gastrointestinal disorders, reflect the versatility of surgical stents in addressing diverse medical needs. End-user segmentation highlights hospitals as the primary users of stents due to their comprehensive surgical capabilities and high patient volumes. Clinics and specialized surgical centers are also notable contributors, offering cost-effective and accessible stent-based interventions for outpatient and minimally invasive procedures.

Global Surgical Stents Segment Analysis

In this report, the Global Surgical Stents Market has been segmented by Products, Types, Material, Application, End User and Geography.

Global Surgical Stents Market, Segmentation by Products

The Global Surgical Stents Market has been segmented by Products into Non-Vascular Stents and Vascular Stents.

Non-vascular stents are used to manage obstructions in ducts and passageways outside the vascular system, such as the biliary ducts, urinary tract, and esophagus. These stents are typically made from materials like silicone or nitinol and are designed to restore or maintain the patency of blocked pathways. They play a crucial role in treating conditions such as biliary strictures, ureteral obstructions, and esophageal cancer, providing patients with minimally invasive and effective solutions. Non-vascular stents have gained significant traction due to their ability to improve quality of life and reduce the need for more invasive surgical interventions.

Vascular stents, including coronary and peripheral artery stents, dominate the market due to their critical role in managing cardiovascular diseases. These stents are designed to open narrowed or blocked arteries, ensuring adequate blood flow and preventing life-threatening complications such as heart attacks or strokes. The introduction of drug-eluting and bioresorbable vascular stents has revolutionized the field, offering enhanced safety and efficacy by reducing the risk of restenosis and late thrombosis. The widespread adoption of vascular stents reflects their vital role in modern cardiology and vascular surgery.

Global Surgical Stents Market, Segmentation by Types

The Global Surgical Stents Market has been segmented by Types into Cardiac Stents, Urinary Stents, Biliary Stents, Oesophageal Stents, Prostatic Stents and Other.

Cardiac stents are the largest segment due to the high prevalence of cardiovascular diseases worldwide. These stents are used to treat coronary artery disease by keeping the arteries open and preventing restenosis, which is a critical application for maintaining heart health. The increasing number of heart surgeries, coupled with advancements in stent technology, is expected to drive the demand for cardiac stents in the forecast period.

Urinary stents are another important segment in the market, commonly used to treat kidney stones, ureteral obstructions, and other urinary tract conditions. These stents help to keep the urinary passages open and allow the normal flow of urine. The rising incidences of urinary tract diseases, including kidney stones and prostate problems, contribute to the growing demand for urinary stents. Biliary stents are used to treat blockages in the bile duct, typically caused by tumors or gallstones, and they are increasingly being used in patients with liver conditions. The global rise in liver diseases and the need for minimally invasive treatment options are boosting the demand for biliary stents.

Oesophageal and prostatic stents are also gaining traction in the market. Oesophageal stents are used to treat patients with esophageal cancer or other conditions that cause narrowing or blockage of the esophagus. These stents provide support and improve swallowing ability in patients. Prostatic stents are used to treat benign prostatic hyperplasia (BPH) and help alleviate urinary obstruction in male patients. The "Other" category includes various niche applications of stents, such as in the treatment of bile duct disorders, gastrointestinal diseases, and in certain specialized surgeries. This wide variety of stent types reflects the expanding range of medical conditions that require stent placement to improve patient outcomes.

Global Surgical Stents Market, Segmentation by Material

The Global Surgical Stents Market has been segmented by Material into Metal, Standard Polymer and Bodegradable Polymer.

Metal stents dominate the market due to their strength, durability, and long-lasting performance. These stents are commonly used in applications such as cardiac and biliary procedures, where structural integrity and resistance to pressure are crucial for maintaining patency over time. The ability to withstand the mechanical stresses in these areas has made metal stents a preferred choice.

Standard Polymer stents are also widely used in the market, particularly for applications where flexibility and ease of placement are more important than long-term durability. These stents are commonly used in urinary tract, gastrointestinal, and vascular surgeries. Their biocompatibility and ability to conform to the shape of the affected area make them suitable for a range of less invasive procedures. As a result, standard polymer stents are popular in outpatient settings and in conditions requiring temporary support.

Biodegradable Polymer stents are an emerging segment in the market, driven by the increasing demand for stents that can naturally dissolve after performing their function, eliminating the need for removal. These stents are often used in cases where temporary support is needed for the healing process, particularly in applications like coronary artery disease and gastrointestinal procedures. Biodegradable stents represent a significant shift towards more patient-friendly and environmentally sustainable options, and they are expected to gain market share as technology advances in this field.

Global Surgical Stents Market, Segmentation by Application

The Global Surgical Stents Market has been segmented by Application into Cardiac Diseases, Urinary Tract Diseases and Other.

Cardiovascular diseases, particularly coronary artery disease, are among the leading causes of mortality worldwide, resulting in the widespread use of stents to maintain the patency of blood vessels. Stent placement has become a standard procedure for treating blockages in coronary arteries, contributing to the dominance of this application segment within the market.

In addition to cardiac applications, the urinary tract diseases segment also holds a significant share of the market. Surgical stents are frequently used in the treatment of kidney stones, ureteral obstructions, and other urinary tract conditions. These stents ensure proper flow of urine and prevent blockages, making them essential in managing urinary tract diseases and contributing to the growth of this segment in the surgical stents market.

The "Other" category within the surgical stents market encompasses a variety of applications in conditions such as gastrointestinal, biliary, and respiratory diseases. Stents are used in procedures like treating obstructed bile ducts, esophageal strictures, and tracheal blockages. Although this segment is relatively smaller compared to cardiac and urinary applications, it still plays a crucial role in expanding the use of surgical stents across different medical specialties.

Global Surgical Stents Market, Segmentation by End User

The Global Surgical Stents Market has been segmented by End User into Hospital, Clinics and Other.

Hospitals are expected to hold the largest market share due to their advanced medical facilities and the high volume of surgical procedures performed, many of which require stent implantation. Hospitals offer specialized care for a wide range of conditions, including cardiac, urinary, and biliary diseases, driving the demand for surgical stents.

Clinics are also an important segment of the market as they cater to outpatient procedures, including less complex surgeries where stents are commonly used. The growing number of specialized clinics for cardiac, urology, and gastroenterology treatments further contributes to the demand for stents in these settings. Clinics offer convenience for patients seeking less invasive treatments, which helps in increasing the adoption of surgical stents.

The Other category encompasses other healthcare settings, such as ambulatory surgical centers, homecare, and long-term care facilities, where stents are used for various treatments. As more surgical procedures move to outpatient settings and with the increased focus on minimally invasive treatments, the demand for stents in these non-hospital environments is also expected to grow. This segmentation highlights the diverse range of healthcare settings utilizing surgical stents for different medical conditions.

Global Surgical Stents Market, Segmentation by Geography

In this report, the Global Surgical Stents Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Surgical Stents Market Share (%), by Geographical Region, 2024

The report covers various countries, including the U.S., Canada, and Mexico in North America; Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and the Rest of Europe in Europe; China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and the Rest of Asia-Pacific (APAC); Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and the Rest of the Middle East and Africa (MEA); and Brazil, Argentina, and the Rest of South America in South America.

North America leads the stents market, primarily due to the rising adoption of sedentary lifestyles, resulting in obesity and an increase in cardiovascular diseases in the region. In contrast, the Asia-Pacific (APAC) region is expected to see significant growth from 2022 to 2029, driven by increasing healthcare awareness. The report also provides detailed insights into market impacts from changes in local regulations, value chain analysis, technical trends, and Porter’s Five Forces analysis. Additionally, it covers challenges faced by global brands due to local competition, tariffs, and trade routes, which are considered while forecasting the market trends for specific countries.

This report provides an in depth analysis of various factors that impact the dynamics of Global Surgical Stents Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Rising Prevalence of Cardiovascular Diseases
• Growing Adoption of Minimally Invasive Procedures
• Technological Advancements in Stent Design

• Increasing Geriatric Population-The aging global population is a critical driver of the surgical stents market, as older individuals are more prone to chronic conditions such as cardiovascular and urological diseases. According to the United Nations, the population aged 65 and above is projected to double by 2050, reaching approximately 1.5 billion. This demographic shift underscores the increasing need for stent-based interventions to manage age-related diseases effectively. Older patients often require minimally invasive and low-risk surgical solutions, making stents an ideal option for ensuring optimal clinical outcomes.

  The rise in life expectancy and the emphasis on active aging further contribute to the demand for surgical stents. Elderly patients, particularly those with comorbidities, benefit from advanced stent technologies such as drug-eluting and bioresorbable stents, which offer improved safety profiles and reduced postoperative complications. This trend highlights the critical role of stents in enhancing the quality of life for geriatric patients and underscores their growing importance in modern healthcare systems.

Restraints:

• High Cost of Advanced Stents
• Complications Associated with Stent Implantation
• Stringent Regulatory Approval Processes

• Limited Access to Healthcare in Developing Regions-Despite the advancements in stent technology and their proven efficacy, limited access to healthcare in low-income and developing regions remains a significant challenge. In many countries, inadequate healthcare infrastructure, lack of trained medical professionals, and high costs of stent-based procedures restrict their widespread adoption. According to the WHO, over half of the world’s population lacks access to essential healthcare services, which hinders the growth potential of the surgical stents market in these regions.

  Addressing this restraint requires concerted efforts to improve healthcare infrastructure, increase affordability, and enhance awareness about the benefits of stent-based interventions. Public and private sector collaborations, along with initiatives to promote health insurance coverage, can help bridge the gap and ensure that life-saving stent technologies are accessible to patients in need, regardless of their geographical location or socioeconomic status.

Opportunities:

• Emergence of Biodegradable Stents
• Expanding Healthcare Infrastructure in Emerging Markets
• Integration of Digital Health Technologies

• Rising Demand for Personalized Medicine-The growing emphasis on personalized medicine presents a significant opportunity for the surgical stents market. Personalized medicine tailors medical treatment to individual patient characteristics, including genetic, environmental, and lifestyle factors. This approach has gained traction in cardiology and oncology, where precise and patient-specific interventions are critical for achieving optimal outcomes. Customizable stents, designed to cater to unique anatomical and pathological conditions, align perfectly with the goals of personalized medicine.

  Advancements in imaging technologies, data analytics, and 3D printing have facilitated the development of bespoke stents that fit patients’ unique anatomical structures and reduce the risk of complications. This innovation not only improves the efficacy of stent-based treatments but also enhances patient satisfaction and long-term outcomes. The rising demand for personalized medical solutions is expected to drive significant growth in the surgical stents market, opening new avenues for innovation and market expansion.